FDA's Peripheral and CNS Drugs Advisory Committee
Executive Summary
Closed Dec. 20 meeting will focus on trade secret and/or confidential commercial information relevant to IND application 30,045. Panel will meet in Conference Room G at FDA's Parklawn Building....